治験管理サービスの世界市場：市場規模・シェア・動向分析 (サービス別・適応症別・最終用途別・地域別・セグメント別、2025年～2030年)

治験管理サービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の治験管理サービス市場規模は2030年までに538億5,000万米ドルに達すると予測されています。

同市場は2025年から2030年にかけてCAGR 8.26%で拡大する見込みです。治験活動のアウトソーシング傾向の高まり、先端治療の研究開発の活発化、治験の世界化などが、市場の成長を促す主な要因となっています。

治験の件数は過去20年間で大幅に増加しています。その背景には、有効性を向上させた新規医薬品に対するニーズの高まりや、最先端医療技術の浸透があります。Clinical trials.govによると、2020年の治験総数は325,773件であったのに対し、2022年4月現在、今年の治験総数は410,903件を超えています。

臨床モニタリング、データ管理、施設モニタリング、メディカルライティングサービスなどの治験管理サービスは、費用対効果に優れ、時間を節約できます。これらはまた、施設間の臨床データの調和や失敗率の軽減にもつながります。さらに、クラウドコンピューティング、人工知能 (AI)、ビッグデータ処方、予測分析、医療用IoT、モバイル技術などのデジタル技術の統合は、依然として大きな発展途上にあります。これらの技術は、治験のペースを加速させながら生産性を向上させる上で大きな可能性を示しています。

COVID-19の大流行は市場に大きな影響を与えました。COVID-19の流行は市場に大きな影響を与え、治験の実施に代わる解決策に対する予想外の緊急性を生み出し、現場でのモニタリング訪問を制限しました。COVID-19感染の拡大を抑え、同時に臨床研究を機能させるために、研究者は遠隔治験モニタリングサービスやプラットフォームを利用するようになりました。例えば、2020年のフローレンス調査によると、60%以上の治験施設と治験スポンサーが、臨床研究のための遠隔サイトモニタリングソリューションを50%以上受け入れていると述べています。

治験管理サービス市場：分析概要

• 治験モニタリング分野が2024年の治験管理サービス業界を支配しました。
• 2024年に治験管理サービス業界を支配したのは腫瘍学分野でした。がん研究開発投資の増加、がん罹患率の増加、個別化された薬物療法への需要の高まりに加え、がん分野における革新的な開発が急増していることが成長の主な要因となっています。
• 2024年の治験管理サービス業界は、医薬品セグメントが支配的でした。これは、過去20年間における研究開発投資の増加と新薬開発に大きく起因しています。
• 北米が治験管理サービス市場を独占しました。新治療法や新薬の需要により、同地域全体で治験が急増しました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 治験管理サービス市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 治験管理サービス市場：分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 治験管理サービス市場：サービス別の推定・動向分析

• セグメントダッシュボード
• 世界の治験管理サービス市場：変動分析、サービス別
• 世界の治験管理サービス市場規模と動向分析、サービス別 (2018～2030年)
• 治験モニタリング
• 規制当局への提出
• 治験データ管理
• メディカルライティング
• サイト管理
• プロジェクト管理
• その他

第5章 治験管理サービス市場：適応症別の推定・動向分析

• セグメントダッシュボード
• 世界の治験管理サービス市場：変動分析、適応症別
• 世界の治験管理サービス市場規模と動向分析、適応症別 (2018～2030年)
• 自己免疫/炎症
• 疼痛管理
• 腫瘍学
• 中枢神経系疾患
• 糖尿病
• 肥満
• 心臓血管
• その他

第6章 治験管理サービス市場：最終用途別の推定・動向分析

• セグメントダッシュボード
• 世界の治験管理サービス市場：変動分析、最終用途別
• 世界の治験管理サービス市場規模と動向分析、最終用途別 (2018～2030年)
• 製薬
• バイオ医薬品
• 医療機器

第7章 治験管理サービス市場：地域別推定・動向分析

• 地域別の市場ダッシュボード
• 世界市場のスナップショット：地域別
• 市場規模の予測・動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
  • 市場リーダー
  • 新興企業
• 企業の市場ポジション分析
• 企業プロファイル
  • CTI Clinical Trial &Consulting
  • Charles River Laboratories
  • Medpace Holdings, Inc.
  • Wuxi Apptec
  • SGS Societe Generale de Surveillance SA
  • Laboratory Corporation of America Holdings
  • IQVIA, Inc.
  • Syneous Health
  • Atlantic Research Group
  • ICON Plc

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 4 Global Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 5 Global Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 6 Global Clinical Trial Management Services, by Region, 2018 - 2030 (USD Million)
• Table 7 North America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
• Table 8 North America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 9 North America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 10 North America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 11 U.S. Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 12 U.S. Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 13 U.S. Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 14 Canada Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 15 Canada Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 16 Canada Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 17 Mexico Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 18 Mexico Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 19 Mexico Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 20 Europe Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
• Table 21 Europe Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 22 Europe Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 23 Europe Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 24 Germany Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 25 Germany Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 26 Germany Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 27 UK Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 28 UK Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 29 UK Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 30 France Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 31 France Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 32 France Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 33 Italy Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 34 Italy Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 35 Italy Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 36 Spain Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 37 Spain Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 38 Spain Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 39 Denmark Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 40 Denmark Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 41 Denmark Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 42 Sweden Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 43 Sweden Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 44 Sweden Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 45 Norway Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 46 Norway Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 47 Norway Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 52 China Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 53 China Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 54 China Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 55 Japan Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 56 Japan Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 57 Japan Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 58 India Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 59 India Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 60 India Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 61 South Korea Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 62 South Korea Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 63 South Korea Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 64 Australia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 65 Australia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 66 Australia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 67 Thailand Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 68 Thailand Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 69 Thailand Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 70 Latin America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
• Table 71 Latin America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 72 Latin America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 73 Latin America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 74 Brazil Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 75 Brazil Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 76 Brazil Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 77 Argentina Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 78 Argentina Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 79 Argentina Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 84 South Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 85 South Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 86 South Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 90 UAE Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 91 UAE Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 92 UAE Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
• Table 93 Kuwait Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
• Table 94 Kuwait Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
• Table 95 Kuwait Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Clinical Trial Management Services, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 Porter's Five Forces Analysis
• Fig. 10 PESTEL Analysis
• Fig. 11 Regional Marketplace: Key Takeaways
• Fig. 12 Global Clinical Trial Management Services, for Clinical Trial Monitoring, 2018 - 2030 (USD Million)
• Fig. 13 Global Clinical Trial Management Services, for Regulatory Submissions, 2018 - 2030 (USD Million)
• Fig. 14 Global Clinical Trial Management Services, for Clinical Trial Data Management, 2018 - 2030 (USD Million)
• Fig. 15 Global Clinical Trial Management Services, for Medical Writing, 2018 - 2030 (USD Million)
• Fig. 16 Global Clinical Trial Management Services, for Site Management, 2018 - 2030 (USD Million)
• Fig. 17 Global Clinical Trial Management Services, for Project Management, 2018 - 2030 (USD Million)
• Fig. 18 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
• Fig. 19 Global Clinical Trial Management Services, for Autoimmune/Inflammation, 2018 - 2030 (USD Million)
• Fig. 20 Global Clinical Trial Management Services, for Pain Management, 2018 - 2030 (USD Million)
• Fig. 21 Global Clinical Trial Management Services, for Oncology, 2018 - 2030 (USD Million)
• Fig. 22 Global Clinical Trial Management Services, for CNS Conditions, 2018 - 2030 (USD Million)
• Fig. 23 Global Clinical Trial Management Services, for Diabetes, 2018 - 2030 (USD Million)
• Fig. 24 Global Clinical Trial Management Services, for Obesity, 2018 - 2030 (USD Million)
• Fig. 25 Global Clinical Trial Management Services, for Cardiovascular, 2018 - 2030 (USD Million)
• Fig. 26 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
• Fig. 27 Global Clinical Trial Management Services, for Pharmaceuticals, 2018 - 2030 (USD Million)
• Fig. 28 Global Clinical Trial Management Services, for Biopharmaceuticals, 2018 - 2030 (USD Million)
• Fig. 29 Global Clinical Trial Management Services, for Medical Devices, 2018 - 2030 (USD Million)
• Fig. 30 Regional Outlook, 2023 & 2030
• Fig. 31 North America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 US Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Canada Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Mexico Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Europe Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Germany Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 UK Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 France Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Italy Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Spain Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Denmark Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Sweden Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Norway Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Asia Pacific Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Japan Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 China Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 India Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Australia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 South Korea Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Thailand Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Latin America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Brazil Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Argentina Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Middle East and Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 South Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 UAE Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Clinical Trial Management Services Market Growth & Trends:

The global clinical trial management services market size is anticipated to reach USD 53.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.26% from 2025 to 2030. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.

The number of clinical trials has significantly increased in the past two decades. This is due to the rising need for novel pharmaceutical products with improved efficacy as well as the increasing penetration of cutting-edge medical technologies. According to Clinical trials.gov, the total number of clinical trials accounted for 325,773 in 2020, whereas, as of April 2022, the number of clinical trials this year totaled more than 410,903.

Clinical trial management services such as clinical monitoring, data management, site monitoring, and medical writing service are cost-effective and time-saving. These also harmonize clinical data across sites and failure rates. Furthermore, the integration of digital technologies, including cloud computing, Artificial Intelligence (AI), big data prescriptive, and predictive analytics, the Internet of Medical Things, and mobile technology remain major developments on the horizon. These technologies have shown great promise in improving productivity while accelerating the pace of clinical trials.

The COVID-19 pandemic significantly impacted the market. It created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function in clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

Clinical Trial Management Services Market Report Highlights:

• The clinical trial monitoring segment dominated the clinical trial management services industry in 2024.
• The oncology segment dominated the clinical trial management services industry in 2024. The rise in oncology R&D investments, the increasing cancer incidences, and the growing demand for personalized medications, coupled with a surge in innovative developments in the field of oncology, are the key factors driving the growth.
• The pharmaceuticals segment dominated the clinical trial management services industry in 2024. This can be largely attributed to the rise in R&D investments and the development of new drugs over the past two decades.
• North America dominated the clinical trial management services market. The demand for new therapies and drugs has led to a surge in clinical trials across the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
  • 1.5.1. Region Wise Market: Base Estimates
  • 1.5.2. Global Market: CAGR Calculation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis (Model 1)
  • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.6.4. Bottom-Up Approach (Model 4)
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Management Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing technological advancement in the clinical trial monitoring services
    • 3.2.1.2. Rise in R&D expenditure by pharmaceutical and biopharmaceutical companies
    • 3.2.1.3. Growth in the number of outsourced projects related to clinical trial management services
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost associated with clinical trial management services
    • 3.2.2.2. Stringent regulatory policies for clinical trial management services
• 3.3. Clinical Trial Management Services Market: Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Management Services Market: Services Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Clinical Trial Management Services Market, Services Movement Analysis
• 4.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
• 4.4. Clinical Trial Monitoring
  • 4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 4.5. Regulatory Submissions
  • 4.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 4.6. Clinical Trial Data Management
  • 4.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 4.7. Medical Writing
  • 4.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 4.8. Site Management
  • 4.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 4.9. Project Management
  • 4.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 4.10. Others
  • 4.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Management Services Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Clinical Trial Management Services Market, Indication Movement Analysis
• 5.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 5.4. Autoimmune/Inflammation
  • 5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.5. Pain Management
  • 5.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.6. Oncology
  • 5.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.7. CNS Conditions
  • 5.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.8. Diabetes
  • 5.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.9. Obesity
  • 5.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.10. Cardiovascular
  • 5.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.11. Others
  • 5.11.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Management Services Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Clinical Trial Management Services Market, End Use Movement Analysis
• 6.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceuticals
  • 6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 6.5. Biopharmaceuticals
  • 6.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 6.6. Medical Devices
  • 6.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Management Services Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Global Regional Market Snapshot
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.4. North America
  • 7.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Scenario
    • 7.5.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Scenario
    • 7.5.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Scenario
    • 7.5.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Scenario
    • 7.5.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Scenario
    • 7.5.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.3. Japan
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Scenario
    • 7.6.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Scenario
    • 7.6.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Scenario
    • 7.6.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Scenario
    • 7.6.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Scenario
    • 7.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Scenario
    • 7.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Scenario
    • 7.8.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Scenario
    • 7.8.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Scenario
    • 7.8.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Scenario
    • 7.8.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
  • 8.1.1. Market Leaders
  • 8.1.2. Emerging Players
• 8.2. Company Market Position Analysis
• 8.3. Company Profiles
  • 8.3.1. CTI Clinical Trial & Consulting
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Charles River Laboratories
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Medpace Holdings, Inc.
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Wuxi Apptec
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. SGS Societe Generale de Surveillance SA
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Laboratory Corporation of America Holdings
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. IQVIA, Inc.
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Syneous Health
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Atlantic Research Group
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. ICON Plc
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives